3D fractal dimension analysis of CT imaging for microvascular invasion prediction in hepatocellular carcinoma - Scorecard - MDSpire

3D fractal dimension analysis of CT imaging for microvascular invasion prediction in hepatocellular carcinoma

  • By

  • Feng Che

  • Qian Li

  • Wei Ren

  • Hehan Tang

  • Guli Zaina

  • Shan Yao

  • Ning Zhang

  • Shaocheng Zhu

  • Bin Song

  • Yi Wei

  • August 7, 2025

  • 0 min

Share

Clinical Scorecard: Analysis of 3D Fractal Dimensions in CT Imaging for Predicting Microvascular Invasion in Hepatocellular Carcinoma

At a Glance

CategoryDetail
ConditionHepatocellular carcinoma (HCC) with microvascular invasion (MVI)
Key MechanismsMicrovascular invasion involves tumor cell presence in small vessels, influencing tumor recurrence and prognosis; fractal analysis quantifies tumor morphological complexity related to vascularization
Target PopulationAdult patients (≥18 years) with pathologically confirmed HCC undergoing preoperative contrast-enhanced CT
Care SettingPreoperative imaging assessment and surgical planning in tertiary medical centers

Key Highlights

  • MVI is a critical histopathological factor linked to poor prognosis and tumor recurrence in HCC.
  • Preoperative identification of MVI is limited by reliance on surgical specimens; current radiological and clinical markers have subjective limitations.
  • Fractal dimension analysis of 3D tumor morphology on contrast-enhanced CT offers an objective quantitative method to assess microvascular complexity and predict MVI status.

Guideline-Based Recommendations

Diagnosis

  • Definitive MVI diagnosis requires histopathological examination of surgical specimens.
  • Preoperative prediction of MVI can be enhanced by assessing tumor morphology using fractal dimension analysis on contrast-enhanced CT.
  • Consider integrating fractal analysis with clinical factors (tumor size, number, AFP levels) for improved MVI risk estimation.

Management

  • Patients with predicted MVI may require wider surgical resection margins.
  • Neoadjuvant or adjuvant therapies should be considered in HCC patients with MVI to reduce recurrence risk.
  • MVI status influences eligibility and prognosis in liver transplantation decisions.

Monitoring & Follow-up

  • Postoperative survival outcomes should be monitored in relation to preoperative fractal dimension findings.
  • Regular imaging follow-up is recommended to detect tumor recurrence, especially in patients with MVI.

Risks

  • Subjective interpretation of radiological features can lead to interobserver variability.
  • Exclusion of patients with prior HCC treatments or macroscopic vascular invasion is necessary to avoid confounding fractal analysis results.

Patient & Prescribing Data

HCC patients undergoing curative resection with available preoperative contrast-enhanced CT imaging

Fractal dimension analysis may guide surgical planning and adjuvant therapy decisions by predicting MVI presence, potentially improving individualized treatment strategies.

Clinical Best Practices

  • Standardize CT imaging protocols and preprocessing (resampling, intensity normalization) for consistent fractal analysis.
  • Use 3D tumor segmentation on portal venous phase images focusing on the largest tumor in multifocal cases.
  • Employ fractal dimension box-counting methods with curve-fitting techniques to quantify tumor morphological complexity.
  • Combine fractal analysis results with clinical and pathological data for comprehensive MVI risk assessment.
  • Ensure reproducibility by validating inter-reader and intra-reader segmentation consistency.

References

Original Source(s)

Related Content